Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cytiva, formerly GE Healthcare Life Sciences, is a global leader in life sciences providing technologies and services that advance and accelerate the development and manufacture of therapeutics. The company offers a comprehensive portfolio of bioprocessing systems, consumables, and laboratory products, including well-known brands such as ÄKTA, Amersham, HyClone, and MabSelect. Cytiva's solutions support the entire drug development lifecycle, from basic research and protein discovery to large-scale commercial manufacturing of biologics, cell therapies, and vaccines. As a key operating company within Danaher Corporation's Life Sciences segment, Cytiva serves a diverse customer base ranging from academic researchers to multinational pharmaceutical companies. The company is instrumental in the production of a significant majority of FDA-approved biological therapies, emphasizing its critical role in the global healthcare ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Global Life Sciences.